MX2017011040A - Agente para el tratamiento de infeccion respiratoria. - Google Patents

Agente para el tratamiento de infeccion respiratoria.

Info

Publication number
MX2017011040A
MX2017011040A MX2017011040A MX2017011040A MX2017011040A MX 2017011040 A MX2017011040 A MX 2017011040A MX 2017011040 A MX2017011040 A MX 2017011040A MX 2017011040 A MX2017011040 A MX 2017011040A MX 2017011040 A MX2017011040 A MX 2017011040A
Authority
MX
Mexico
Prior art keywords
treating agent
respiratory infection
infection treating
dihydroquinoli
fluoropyrrolidine
Prior art date
Application number
MX2017011040A
Other languages
English (en)
Inventor
Kume Kota
Yoshida Hisao
ANDO Hirotaka
Tanaka Yuta
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Publication of MX2017011040A publication Critical patent/MX2017011040A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

[Problema] La presente invención se refiere a un agente para el tratamiento de infección respiratoria más seguro y más efectivo. [Solución] Un agente para el tratamiento de infección respiratoria contiene, como un ingrediente activo, ácido 7-[(3S,4S)-3-{(ciclopropilamino)metil}-4-fluoropirrolidin-1-il]-6 -fluoro-1-(2-fluoroetil)-8-metoxi-4-oxo-1,4-dihidroquinolin-3-car boxílico o una sal farmacéuticamente aceptable del mismo.
MX2017011040A 2015-03-13 2016-03-11 Agente para el tratamiento de infeccion respiratoria. MX2017011040A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2015051206 2015-03-13
JP2015136944 2015-07-08
PCT/JP2016/057797 WO2016148066A1 (ja) 2015-03-13 2016-03-11 呼吸器感染症治療剤

Publications (1)

Publication Number Publication Date
MX2017011040A true MX2017011040A (es) 2017-11-10

Family

ID=56920174

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017011040A MX2017011040A (es) 2015-03-13 2016-03-11 Agente para el tratamiento de infeccion respiratoria.

Country Status (15)

Country Link
US (3) US20180042918A1 (es)
EP (1) EP3269369A4 (es)
JP (1) JP6077725B1 (es)
KR (1) KR102532681B1 (es)
CN (2) CN113975277A (es)
AU (1) AU2016234411C1 (es)
BR (1) BR112017019205A2 (es)
CA (1) CA2978261A1 (es)
EA (1) EA201791995A1 (es)
IL (1) IL253878A0 (es)
MX (1) MX2017011040A (es)
MY (1) MY191848A (es)
PH (1) PH12017501505A1 (es)
SG (2) SG10201908007UA (es)
WO (1) WO2016148066A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI818910B (zh) * 2017-06-16 2023-10-21 日商杏林製藥股份有限公司 吸入性肺炎、肺化膿症或肺膿瘍之治療劑
EA202090066A1 (ru) * 2018-03-30 2020-04-15 Керин Фармасьютикал Ко., Лтд. Терапевтическое средство для лечения аспирационной пневмонии, легочного нагноения или абсцесса легких

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW425394B (en) * 1996-04-24 2001-03-11 Daiichi Seiyaku Co Antimicrobial quinolone derivatives having 3-(N-cycloalkyl) aminomethylpyrrolidine group
EP1486500B1 (en) * 2002-03-18 2009-09-16 Kyorin Pharmaceutical Co., Ltd. 10-(3-cyclopropylaminomethyl-1-pyrrolidinyl)pyridobenzoxazinecarboxylic acid derivative effective against resistant bacteria
PT1666477E (pt) * 2003-09-10 2013-08-28 Kyorin Seiyaku Kk Derivado de 7-(4-substituído-3-ciclopropilaminometil-1- pirrolidinil) quinolonecarboxílico
DE102007027618A1 (de) 2007-06-12 2008-12-18 Rehau Ag + Co Verfahren zur Vorbehandlung von zu lackierenden polymeren Oberflächen
SA112330992B1 (ar) * 2011-11-10 2015-09-13 كيورين فارماسوتيكال كو.، ليمتد صورة متبلرة من 7-{(s4، s3)-3-[(سيكلو بروبيل أمينو) ميثيل]-4-فلورو بيروليدين-1-يل}-6-فلورو-1-(2-فلورو إيثيل)- 8-ميثوكسي-4-أوكسو-1، 4-داي هيدرو كينولين-3- حمض كربوكسيلي
JP6062422B2 (ja) * 2012-03-29 2017-01-18 杏林製薬株式会社 カプセル製剤
WO2014174848A1 (ja) * 2013-04-25 2014-10-30 杏林製薬株式会社 錠剤

Also Published As

Publication number Publication date
CN107427507B (zh) 2021-12-17
KR20170123695A (ko) 2017-11-08
JPWO2016148066A1 (ja) 2017-04-27
EA201791995A1 (ru) 2017-12-29
US20190076421A1 (en) 2019-03-14
BR112017019205A2 (pt) 2018-04-24
WO2016148066A1 (ja) 2016-09-22
EP3269369A1 (en) 2018-01-17
AU2016234411C1 (en) 2020-04-30
SG10201908007UA (en) 2019-10-30
US20180042918A1 (en) 2018-02-15
AU2016234411A1 (en) 2017-09-07
US10918634B2 (en) 2021-02-16
KR102532681B1 (ko) 2023-05-15
CA2978261A1 (en) 2016-09-22
AU2016234411B2 (en) 2020-01-30
JP6077725B1 (ja) 2017-02-08
SG11201706951XA (en) 2017-09-28
MY191848A (en) 2022-07-18
PH12017501505B1 (en) 2018-02-05
CN113975277A (zh) 2022-01-28
PH12017501505A1 (en) 2018-02-05
IL253878A0 (en) 2017-10-31
EP3269369A4 (en) 2018-11-07
US20210052572A1 (en) 2021-02-25
CN107427507A (zh) 2017-12-01

Similar Documents

Publication Publication Date Title
PH12018502747A1 (en) Boronic acid derivatives and therapeutic uses thereof
PH12020551089A1 (en) Pyrrolopyrimidine compounds used as tlr7 agonist
MX2016016593A (es) Nuevos derivados de aminoalquibenzotiazepina y usos de los mismos.
NZ733174A (en) Quinazoline derivatives used to treat hiv
NZ733125A (en) Isoquinoline compounds for the treatment of hiv
PH12016502003A1 (en) Novel bacteriophage and composition containing same
PH12015501891A1 (en) Novel bacteriophage and antibacterial composition comprising the same
PH12015501890A1 (en) Novel bacteriophage and antibacterial composition comprising the same
PH12017502376A1 (en) Oral solid formulation containing irinotecan and method of preparing the same
HK1251565A1 (zh) 用於製備(4s)-4-(4-氰基-2-甲氧基苯基)-5-乙氧基-2，8-二甲基-1，4-二氫-1，6-萘啶-3-甲酰胺的方法及其用於用作藥物活性物質的純化
EP4234021A3 (en) Pharmaceutical composition comprising an adenosine derivative for use in the prevention or treatment of diabetic nephropathy
PH12017501505A1 (en) Respiratory infection treating agent
EP3311817A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF EYES DISEASES WITH IMATINIB AS AN ACTIVE SUBSTANCE
MX2019008338A (es) Composicion farmaceutica que contiene sulglicotido o una sal farmaceuticamente aceptable del mismo para la prevencion o tratamiento del ojo seco.
MX365021B (es) Composicion para tratar o prevenir enfermedades ocasionadas por permeabilidad vascular, que contiene como ingrediente activo imatinib o una sal farmaceuticamente aceptable del mismo.
ZA201807495B (en) Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereof
PH12019502835A1 (en) Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess
WO2018084817A3 (en) A new form of active agent
ZA201803722B (en) Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof
EA033921B9 (ru) Производные сиаловой кислоты и их применение в лечении инфекций, вызываемых вирусом гриппа
UA88315U (en) Antibacterial composition
UA91125U (uk) Антибактеріальна композиція